• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估住院糖尿病患者对全院血糖控制方案的偏好:一项离散选择实验

Evaluating Preferences of Hospitalized Diabetes Patients for Hospital-Wide Glycemic Control Programme: A Discrete Choice Experiment.

作者信息

Dai Jing, He Ting, He Xiaodie, Li Huaying, Li Lintong, Sun Jie, Pan Jie, Ji Cheng

机构信息

Department of Pharmacy The Second Affiliated Hospital of Soochow University, Suzhou, China.

Department of Pharmacy China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China.

出版信息

J Diabetes Res. 2024 Sep 6;2024:2552658. doi: 10.1155/2024/2552658. eCollection 2024.

DOI:10.1155/2024/2552658
PMID:39280993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11398954/
Abstract

Effective glycemic control is crucial for hospitalized patients, leading to benefits such as shorter hospital stays and reduced postoperative infection rates. While previous studies have emphasized the effectiveness of multidisciplinary collaborative stewardship for hospital-wide hyperglycemia management, patient perspectives and preferences have not been adequately considered. To identify factors influencing treatment preferences of Chinese hospitalized diabetes patients using discrete choice experiments (DCEs) and provide practical insights for the construction of a hospital-wide glycemic control programme. A face-to-face survey was conducted among diabetes patients admitted to nonendocrine departments in a tertiary hospital in Nanjing, China. The attributes and levels were determined based on DCE principles, and a conditional logit model was used to quantify patients' preferences. A total of 157 respondents were analyzed. Antihyperglycemic effectiveness, healthcare providers, treatment regimen, monitoring frequency, and adverse reactions were the five attributes that significantly influenced patient preference ( < 0.05). Notably, an 80% glycemic control rate ( = 2.009) and a multidisciplinary management team involving clinical pharmacists ( = 1.346) had the greatest impact. Negative effects were observed for hypoglycemia ( = -1.008), insulin pump use ( = -0.746), and frequent glucose monitoring ( = -0.523). Female patients exhibited higher concern for healthcare providers ( = 1.172) compared to males. Younger and shorter-course patients prioritized antihyperglycemic effectiveness ( = 3.330, = 1.510), while older patients preferred multidisciplinary management ( = 1.186) and opposed increased monitoring frequency ( = -0.703). Patients with higher educational backgrounds showed greater acceptance of continuous glucose monitoring ( = 1.983), and those with higher annual income placed more emphasis on glycemic control rate. Treatment preferences of hospitalized diabetes patients are mainly influenced by antihyperglycemic effectiveness, adverse reactions, healthcare providers, and individual characteristics. Comprehensive consideration and an individualized therapy strategy should be given when constructing a hospital-wide glycemic control programme.

摘要

有效的血糖控制对住院患者至关重要,可带来缩短住院时间和降低术后感染率等益处。虽然先前的研究强调了多学科协作管理对全院高血糖管理的有效性,但患者的观点和偏好尚未得到充分考虑。本研究旨在通过离散选择实验(DCE)确定影响中国住院糖尿病患者治疗偏好的因素,并为构建全院血糖控制方案提供实践见解。在中国南京一家三级医院的非内分泌科室住院的糖尿病患者中进行了面对面调查。根据DCE原则确定属性和水平,并使用条件logit模型量化患者的偏好。共分析了157名受访者。降糖效果、医护人员、治疗方案、监测频率和不良反应是显著影响患者偏好的五个属性(<0.05)。值得注意的是,80%的血糖控制率(=2.009)和包括临床药师的多学科管理团队(=1.346)影响最大。低血糖(=-1.008)、胰岛素泵使用(=-0.746)和频繁血糖监测(=-0.523)产生负面影响。与男性相比,女性患者对医护人员更为关注(=1.172)。病程较短的年轻患者优先考虑降糖效果(=3.330,=1.510),而老年患者则倾向于多学科管理(=1.186),并反对增加监测频率(=-0.703)。受教育程度较高的患者对持续血糖监测的接受度更高(=1.983),年收入较高的患者更注重血糖控制率。住院糖尿病患者的治疗偏好主要受降糖效果、不良反应、医护人员和个体特征的影响。在构建全院血糖控制方案时应综合考虑并制定个体化治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11be/11398954/b860a5f2e918/JDR2024-2552658.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11be/11398954/b860a5f2e918/JDR2024-2552658.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11be/11398954/b860a5f2e918/JDR2024-2552658.001.jpg

相似文献

1
Evaluating Preferences of Hospitalized Diabetes Patients for Hospital-Wide Glycemic Control Programme: A Discrete Choice Experiment.评估住院糖尿病患者对全院血糖控制方案的偏好:一项离散选择实验
J Diabetes Res. 2024 Sep 6;2024:2552658. doi: 10.1155/2024/2552658. eCollection 2024.
2
Addressing hyperglycemia from hospital admission to discharge.处理从住院到出院期间的高血糖问题。
Curr Med Res Opin. 2010 Mar;26(3):589-98. doi: 10.1185/03007990903566822.
3
Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.慎思所求:益处描述对糖尿病患者益处-风险权衡偏好的影响。
Value Health. 2017 Apr;20(4):670-678. doi: 10.1016/j.jval.2016.11.023. Epub 2017 Feb 9.
4
Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.中国 2 型糖尿病患者的糖尿病治疗偏好:一项离散选择实验。
Front Public Health. 2022 Feb 1;9:782964. doi: 10.3389/fpubh.2021.782964. eCollection 2021.
5
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.评估中国 2 型糖尿病患者对口服抗糖尿病药物的偏好和支付意愿:一项离散选择实验。
Patient. 2024 Sep;17(5):565-574. doi: 10.1007/s40271-024-00694-7. Epub 2024 Apr 20.
6
Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.对于新诊断的糖化血红蛋白(HbA1c)>9%的 2 型糖尿病患者,短期强化胰岛素治疗可能是首选。
J Diabetes. 2017 Oct;9(10):890-893. doi: 10.1111/1753-0407.12581. Epub 2017 Aug 22.
7
Inpatient glycemic management in internal medicine: an observational multicenter study in Nanjing, China.内科住院患者血糖管理:中国南京的一项多中心观察性研究。
Curr Med Res Opin. 2017 Aug;33(8):1371-1377. doi: 10.1080/03007995.2017.1330256. Epub 2017 Jun 9.
8
Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.个体化糖尿病管理:糖尿病患者更喜欢什么?一项离散选择实验。
Eur J Health Econ. 2021 Apr;22(3):425-443. doi: 10.1007/s10198-021-01264-6. Epub 2021 Feb 15.
9
Glycemic control in the infectious diseases ward; role of clinical pharmacist interventions.传染病病房的血糖控制;临床药师干预的作用。
J Infect Dev Ctries. 2014 Apr 15;8(4):480-9. doi: 10.3855/jidc.3357.
10
A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.一项离散选择实验,用于量化患者对胰高血糖素样肽-1受体激动剂注射频率在2型糖尿病治疗中的偏好。
Curr Med Res Opin. 2016;32(2):251-62. doi: 10.1185/03007995.2015.1117433. Epub 2015 Nov 30.

本文引用的文献

1
Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.中国 2 型糖尿病患者对抗高血糖药物的偏好:一项全国性调查的结果。
BMJ Glob Health. 2023 Apr;8(4). doi: 10.1136/bmjgh-2022-010942.
2
Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands.糖尿病患者对血糖监测技术的偏好:来自波兰和荷兰的离散选择实验结果。
BMJ Open Diabetes Res Care. 2023 Jan;11(1). doi: 10.1136/bmjdrc-2022-003025.
3
Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study.
中国西北地区 2 型糖尿病患者血脂异常患病率、治疗率及其控制情况的横断面研究。
Lipids Health Dis. 2022 Aug 25;21(1):77. doi: 10.1186/s12944-022-01691-1.
4
Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population.中国老年人群 2 型糖尿病的患病率、知晓率和控制率及相关危险因素分析。
BMC Public Health. 2022 Jul 19;22(1):1382. doi: 10.1186/s12889-022-13759-9.
5
Preference for Type 2 Diabetes Therapies in the United States: A Discrete Choice Experiment.美国对 2 型糖尿病治疗药物的偏好:一项离散选择实验。
Adv Ther. 2022 Sep;39(9):4114-4130. doi: 10.1007/s12325-022-02181-7. Epub 2022 Jul 7.
6
Impact of pharmacist participation in the patient care team on value-based health measures.药师参与患者护理团队对基于价值的健康措施的影响。
Am J Health Syst Pharm. 2022 Sep 22;79(19):1645-1651. doi: 10.1093/ajhp/zxac175.
7
Efficacy of Pharmaceutical Care in Patients with Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial.药学服务对 2 型糖尿病合并高血压患者的疗效:一项随机对照试验。
Int J Clin Pract. 2022 Mar 24;2022:7681404. doi: 10.1155/2022/7681404. eCollection 2022.
8
6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.6. 血糖目标:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S83-S96. doi: 10.2337/dc22-S006.
9
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review.2 型糖尿病患者抗糖尿病药物的依从性和持久性及其与临床和经济结局的关系:系统文献回顾。
Diabetes Obes Metab. 2022 Mar;24(3):377-390. doi: 10.1111/dom.14603. Epub 2021 Dec 9.
10
Improved Patient-Reported Medication Adherence, Patient Satisfaction, and Glycemic Control in a Collaborative Care Pharmacist-Led Diabetes "Tune-Up" Clinic.在协作式护理药师主导的糖尿病“调整”诊所中,患者报告的药物依从性、患者满意度和血糖控制得到改善。
Int J Environ Res Public Health. 2021 Sep 1;18(17):9242. doi: 10.3390/ijerph18179242.